39891-07-1 Usage
Uses
Used in Pharmaceutical Industry:
(5-chloro-pyridin-3-yl)-acetonitrile is used as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure and reactivity contribute to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, (5-chloro-pyridin-3-yl)-acetonitrile serves as an intermediate for the production of agrochemicals, such as pesticides and herbicides. Its incorporation into these compounds can enhance their effectiveness in protecting crops and managing pests.
Used in Medicinal Chemistry and Drug Discovery:
(5-chloro-pyridin-3-yl)-acetonitrile is utilized as a valuable building block in medicinal chemistry and drug discovery. Its properties allow for the creation of novel compounds with potential applications in treating various diseases and medical conditions.
Used in Organic Chemistry:
(5-chloro-pyridin-3-yl)-acetonitrile is also employed in organic chemistry as a versatile reagent for the synthesis of a wide range of organic compounds. Its unique structure and reactivity make it an attractive candidate for use in various chemical reactions and processes.
Check Digit Verification of cas no
The CAS Registry Mumber 39891-07-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,9,8,9 and 1 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 39891-07:
(7*3)+(6*9)+(5*8)+(4*9)+(3*1)+(2*0)+(1*7)=161
161 % 10 = 1
So 39891-07-1 is a valid CAS Registry Number.
39891-07-1Relevant academic research and scientific papers
SUBSTITUTED DIAMINOPYRIMIDYL COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH
-
, (2015/07/02)
Provided herein are diaminopyrimidyl Compounds having the following structures: wherein X, L, R1, and R2 are as defined herein, compositions comprising an effective amount of a Diaminopyrimidyl Compound, and methods for treating or preventing PKC-theta-mediated disorders, or a condition treatable or preventable by inhibition of a kinase, for example, PKC-theta.
